Plant-Based Medicine & Botanicals

This page provides general information only about the field of plant-based medicine. It is not medical advice, and nothing here is intended to recommend, endorse, or guide the use of any substance. Decisions about your health should always be made in consultation with a qualified and registered health practitioner.

"Plant-based medicine" is an umbrella term used in academic and regulatory settings to describe medicinal preparations derived from plants. It overlaps with the older terms herbalism, botanical medicine, and the more technical term phytomedicine. The field spans thousands of years of recorded human practice and, more recently, a body of laboratory and clinical research conducted under the same scientific standards applied to other classes of medicine.

Because the term is broad, it covers a wide spectrum of products. At one end sit everyday culinary herbs and lightly processed botanical preparations; at the other sit highly purified plant-derived compounds that are scheduled, prescription-only medicines. Understanding where a given product sits on that spectrum is essential to understanding how it is regulated and discussed.

Records of plants being used as medicinal preparations appear across nearly every documented civilisation. Ancient Egyptian, Mesopotamian, Chinese, Ayurvedic, and Greco-Roman texts each catalogued plant materials and the contexts in which they were used. These historical records are valuable as cultural and ethnobotanical documents, but they predate the scientific method and cannot be read as evidence of safety or effectiveness by modern standards.

A turning point came in the early nineteenth century, when chemists began isolating individual active compounds from plants. The isolation of morphine from the opium poppy in the early 1800s is often cited as the start of modern pharmacology. Over the following two centuries, many isolated plant compounds became the starting points for pharmaceutical research, and the discipline of pharmacognosy — the study of medicines derived from natural sources — emerged as a formal academic field.

The twentieth century saw two parallel developments. On one hand, the rise of synthetic chemistry meant that many medicines were designed and manufactured rather than extracted from plants. On the other, interest in characterising plant constituents never disappeared, and natural products have continued to serve as inspiration for drug discovery. A significant proportion of approved medicines trace their chemical lineage, directly or indirectly, to compounds first identified in plants, fungi or other natural sources.

It is worth emphasising that historical or traditional use of a plant does not, on its own, establish that a preparation is safe or that it does what tradition claims. Regulators and researchers treat traditional use as background context, not as proof.

A phytomedicine is a medicinal product whose active ingredients are derived from plant material. Unlike a single-molecule pharmaceutical, a plant extract typically contains many different compounds, only some of which may be biologically active. This chemical complexity is one of the defining scientific challenges of the field.

• Whole or crude extracts contain a broad mixture of the plant's constituents.
• Standardised extracts are processed so that one or more marker compounds are present at a defined, consistent concentration.
• Isolated constituents are single compounds purified from the plant, which behave more like conventional small-molecule drugs.

Because the composition of a plant can vary with species, growing conditions, harvest timing, and processing, two products described by the same common plant name may differ substantially in their actual chemistry. This variability is a central reason that quality control matters so much in this field. Even the part of the plant used — root, leaf, flower, or seed — can change the chemical profile considerably.

Researchers also distinguish between a plant's marker compounds and its active constituents. A marker compound is simply a chemical that can be reliably measured to confirm identity and consistency; it may or may not be the compound responsible for any biological activity. This distinction is important because measuring a marker is a quality-control tool, not in itself a statement about what a preparation does.

In a regulated setting, manufacturers are expected to control the identity, purity, and consistency of their materials. Researchers and regulators refer to several quality concepts:

• Standardisation — ensuring a defined amount of a known marker compound is present in each batch.
• Identity testing — confirming the raw material is the correct species and plant part.
• Contaminant testing — screening for heavy metals, pesticides, microbial contamination, and adulterants.
• Good Manufacturing Practice (GMP) — a documented quality framework that governs how medicines are produced.

Products that are unregulated or sold outside formal supply chains may not be subject to any of these controls. This is a recognised safety concern discussed widely in the academic and regulatory literature, because a consumer generally cannot verify the contents of such a product. Documented problems with unregulated botanical products have included incorrect species substitution, undeclared ingredients, contamination, and inconsistent concentrations between batches.

It is also a misconception that "natural" automatically means "safe". Many plants produce compounds that are biologically potent, and potency cuts both ways. Interactions between plant constituents and other medicines are a genuine and well-studied phenomenon. This is one of many reasons that questions about any specific preparation should be directed to a qualified health practitioner rather than resolved from general reading.

In Australia, therapeutic goods are regulated by the Therapeutic Goods Administration (TGA). Plant-derived products may fall into different regulatory categories depending on their composition and the claims made about them. Some are regulated as listed or assessed listed complementary medicines, some as registered medicines, and certain plant-derived substances are scheduled as prescription-only or controlled substances.

Scheduling determines how a substance may be accessed. Many substances discussed in this field are Schedule 4 (prescription-only) or Schedule 8 (controlled), meaning they can only be supplied on the authority of a registered medical practitioner and are subject to strict legal controls. Where a product is not entered on the Australian Register of Therapeutic Goods (the ARTG), specific access pathways such as the Special Access Scheme and the Authorised Prescriber Scheme may apply. These pathways are described in more detail on our access page.

The level of evidence a product must demonstrate also depends on its category. Lower-risk listed complementary medicines operate under a different framework to higher-risk registered medicines, which face more extensive pre-market assessment. The claims permitted on a product are likewise tied to its category and to the evidence held to support them. This is why two superficially similar plant products can be regulated very differently.

The strength of scientific evidence varies enormously across the field of plant-based medicine. For some compounds, there is a substantial body of well-designed human research; for many others, the available data are limited to laboratory studies, animal studies, or small, preliminary trials. Researchers describe these as different points on a spectrum of evidence.

An important principle is that promising results in a test tube or animal model do not establish that a substance is safe or effective in humans. Many compounds that look encouraging in early research never demonstrate a benefit in rigorous human trials. For this reason, neutral educational resources describe substances as being studied for or investigated in relation to particular questions, rather than making claims about outcomes.

The complexity of plant extracts adds a further research challenge. When a preparation contains dozens of compounds, attributing any observed effect to a particular constituent — or untangling how constituents might interact — is scientifically difficult. Standardising the test material so that studies can be compared and replicated is itself a hurdle that the field continues to work through.

Because this is a fast-moving and uneven field, the most reliable course for any individual is to discuss specific questions with a qualified health practitioner who can consider the current evidence and the person's individual circumstances.

To summarise the themes on this page:

• Plant-based medicine is a broad field ranging from lightly processed botanicals to scheduled, prescription-only compounds.
• Traditional use offers historical context but is not evidence of safety or effectiveness by modern standards.
• Plant chemistry is complex and variable, which makes quality control, standardisation and Good Manufacturing Practice especially important.
• "Natural" does not mean "safe"; potent plant compounds can interact with other medicines.
• In Australia, the TGA regulates these products, and many relevant substances are prescription-only or controlled.

This page is general information only and is not medical advice. For guidance about your own circumstances, please consult a qualified, registered health practitioner.